Impact of vascular apoE in aging and AD
血管apoE对衰老和AD的影响
基本信息
- 批准号:10667475
- 负责人:
- 金额:$ 54.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAffectAgeAge MonthsAgingAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmyloidAmyloid beta-ProteinApoE knockout mouseApolipoprotein EAstrocytesAtherosclerosisBiochemistryBioinformaticsBiological MarkersBiologyBiometryBlood - brain barrier anatomyBlood VesselsBrainBrain imagingBreedingCell modelCell physiologyCellsCerebral Amyloid AngiopathyCerebrovascular CirculationCerebrovascular DisordersCerebrovascular systemCognitionCollaborationsCouplingDNA cassetteDevelopmentElderlyEnsureExcisionGenesGenotypeGoalsHomeostasisHumanImmune responseImmune systemImpaired cognitionIndividualKnock-in MouseKnock-outKnockout MiceLipoproteinsLiquid substanceLoxP-flanked alleleMeasuresMediatingMetabolismMicrogliaModelingMolecularMolecular ProfilingMusNerve DegenerationNeurogliaOutcomePathogenesisPathogenicityPathologicPathway interactionsPericytesPhasePhenotypePlasmaPlayPropertyProtein IsoformsProteomicsResourcesRisk FactorsRoleSamplingSeveritiesSmooth Muscle MyocytesStatistical Data InterpretationStructural ModelsStudy modelsTestingVascular Cognitive ImpairmentWhite Matter Hyperintensityage relatedamyloid pathologyapolipoprotein E-3beta amyloid pathologybrain parenchymacell typecerebrovascularcognitive functioncognitive performancecomparativedata managementglycationhypercholesterolemiainduced pluripotent stem cellinnovationlipid metabolismlipid transportlipidomicsmetabolomicsmolecular phenotypemouse modelmultiple omicsneuroinflammationneuropathologynoveloxidationparticlepromotersingle-cell RNA sequencingwhite matter damage
项目摘要
PROJECT SUMMARY (APOE U19: Project 4)
While the major function of apolipoprotein E (apoE) is to mediate the lipid transport, APOE genotype (APOE2,
APOE3 and APOE4) significantly influences cognitive function and Alzheimer’s disease (AD) pathogenesis
through multiple pathways. APOE is associated with not only amyloid-β (Aβ) pathology but also cerebrovascular
function including blood-brain barrier integrity and cerebral blood flow. Given that cerebrovascular disturbance
substantially contributes to cognitive decline in the elderly and that apoE is abundantly expressed in vascular
mural cells (smooth muscle cells and pericytes) as well as astrocytes and microglia in the brain, the overall goal
of Project 4 is to define how APOE genotype in vascular mural cells impacts the molecular mechanisms and
pathways in the development of cerebrovascular dysregulations and cognitive decline during aging and AD. In
Aim 1, we will utilize novel mouse models, in which human APOE2, APOE3, or APOE4 gene is expressed upon
an excision of a loxp-flanked STOP cassette by vascular mural cell specific sm22α promoter driven Cre
expression to determine the effects of vascular mural cell-specific expression of apoE isoforms on
cerebrovascular function and brain cognition during aging. In Aim 2, we will define the impact of apoE isoform
deletion in vascular mural cells on age-related cerebrovascular dysfunction and cognitive decline using novel
APOE knock-in mice, in which murine Apoe is replaced with floxed APOE2, APOE3, or APOE4 gene. By
crossing with sm22α-Cre mice, we will specifically delete individual apoE isoforms in vascular mural cells. In Aim
3, we will examine how vascular-specific expression or deletion of apoE isoforms in conditional mouse models
affects AD-related phenotypes by breeding the vascular mural cell-specific apoE isoform expressing or knockout
mice with amyloid model APP knockin mice (AppNL-F/NL-F). Using those unique mouse models, we will
comprehensively investigate how apoE isoforms in vascular mural cells impact cerebrovascular function, glial
phenotypes, neuroinflammation, neurodegeneration, brain cognition and amyloid pathology at different ages. In
particular, the apoE properties in the mouse models will be analyzed by the Biochemistry and Structural
Modeling Core (Core B). ApoE amounts, oxidation and/or glycation in the mice as well as other AD-rerated fluid
biomarkers will be measured through the Biomarker Core (Core D). While neuropathology in the mice will be
investigated in Neuropathology Core (Core C), a multi-Omics approach including proteomics, metabolomics,
lipidomics and single cell RNA sequencing will be carried out through the Multi-Omics Core (Core F) and
Bioinformatics, Biostatistics, and Data Management Core (Core G) to profile molecular phenotypes in these
mouse models. Together, our innovative study should fill a critical void in our understanding of how apoE
isoforms in cerebrovasculature impact cellular functions and brain homeostasis during aging and AD through
synergistic interaction with Core B-G and comparative mouse model studies by Project 2 and Project 3.
项目摘要(APOE U19:项目 4)
虽然载脂蛋白 E (apoE) 的主要功能是介导脂质转运,但 APOE 基因型 (APOE2、
APOE3 和 APOE4) 显着影响认知功能和阿尔茨海默病 (AD) 发病机制
通过多种途径。 APOE 不仅与淀粉样蛋白-β (Aβ) 病理学相关,还与脑血管疾病相关
功能包括血脑屏障完整性和脑血流量。鉴于脑血管障碍
apoE 在很大程度上导致老年人的认知能力下降,并且 apoE 在血管中大量表达
壁细胞(平滑肌细胞和周细胞)以及大脑中的星形胶质细胞和小胶质细胞,总体目标
项目 4 的目的是定义血管壁细胞中的 APOE 基因型如何影响分子机制和
衰老和 AD 期间脑血管失调和认知能力下降的发展途径。在
目标 1,我们将利用新的小鼠模型,其中表达人类 APOE2、APOE3 或 APOE4 基因
通过血管壁细胞特异性 sm22α 启动子驱动的 Cre 切除 loxp 侧翼的 STOP 盒
表达以确定 apoE 亚型的血管壁细胞特异性表达对
衰老过程中的脑血管功能和大脑认知。在目标 2 中,我们将定义 apoE 同工型的影响
血管壁细胞缺失对年龄相关脑血管功能障碍和认知能力下降的影响
APOE 敲入小鼠,其中小鼠 Apoe 被 floxed APOE2、APOE3 或 APOE4 基因取代。经过
与 sm22α-Cre 小鼠杂交,我们将特异性删除血管壁细胞中的单个 apoE 同工型。瞄准
3、我们将研究条件小鼠模型中apoE亚型的血管特异性表达或缺失如何
通过培育血管壁细胞特异性 apoE 亚型表达或敲除来影响 AD 相关表型
淀粉样蛋白模型 APP 敲入小鼠 (AppNL-F/NL-F)。使用这些独特的鼠标模型,我们将
全面研究血管壁细胞apoE亚型如何影响脑血管功能、神经胶质细胞
不同年龄的表型、神经炎症、神经变性、大脑认知和淀粉样蛋白病理。在
特别是,小鼠模型中的 apoE 特性将通过生物化学和结构分析进行分析
建模核心(核心 B)。小鼠中的 ApoE 含量、氧化和/或糖化以及其他 AD 相关液体
生物标记物将通过生物标记物核心(Core D)进行测量。虽然小鼠的神经病理学将
神经病理学核心(核心 C)进行了研究,这是一种多组学方法,包括蛋白质组学、代谢组学、
脂质组学和单细胞 RNA 测序将通过多组学核心(Core F)和
生物信息学、生物统计学和数据管理核心 (Core G),用于分析这些领域的分子表型
鼠标模型。总之,我们的创新研究应该填补我们对 apoE 如何理解的一个关键空白。
脑血管系统中的亚型通过以下方式影响衰老和 AD 过程中的细胞功能和大脑稳态
与 Core B-G 的协同相互作用以及项目 2 和项目 3 的比较小鼠模型研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Takahisa Kanekiyo其他文献
Takahisa Kanekiyo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Takahisa Kanekiyo', 18)}}的其他基金
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
- 批准号:
10629715 - 财政年份:2023
- 资助金额:
$ 54.78万 - 项目类别:
Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain
通过将 VGF 输送至大脑来治疗阿尔茨海默病的治疗策略
- 批准号:
10738951 - 财政年份:2023
- 资助金额:
$ 54.78万 - 项目类别:
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease
增强 APOE2 在大脑中的表达,用于阿尔茨海默病的治疗策略
- 批准号:
10208342 - 财政年份:2021
- 资助金额:
$ 54.78万 - 项目类别:
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease
增强 APOE2 在大脑中的表达,用于阿尔茨海默病的治疗策略
- 批准号:
10514954 - 财政年份:2021
- 资助金额:
$ 54.78万 - 项目类别:
Pathogenic mechanisms of ABCA7 in Alzheimer's disease
ABCA7在阿尔茨海默病中的发病机制
- 批准号:
9221000 - 财政年份:2017
- 资助金额:
$ 54.78万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 54.78万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 54.78万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 54.78万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 54.78万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 54.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 54.78万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 54.78万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 54.78万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 54.78万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 54.78万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




